MAKO Surgical reported a 19 percent increase in revenue for the second quarter of 2013 over the same period last year.
The company also reported 10 RIO systems sold during the second quarter, eight to domestic customers. The company's revenue totaled $28.2 million for the quarter. The company also reported a 26 percent increase in MAKOplasty procedures performed during the second quarter, and 28 percent increase for the first half of the year.
As of June 30, there were 171 RIO systems installed worldwide and 111 that include the company's total hip arthroplasty application. However, the company reported net loss for the three month's end at $19.7 million, including non-cash and non-operating expenses of $6.9 million associated with the change in fair value of derivative assets related to a credit facility agreement.
Net loss for the six months end was $29.3 million, including a $4.4 million non-cash inventory valuation adjustment for excess hip implant inventory and a $2.3 million non-cash asset impairment charge associated with him implant instrumentation.
More Articles on Orthopedic and Spine Devices:
Symmetry Medical Reports Flat 2Q Revenue, Net Income Down 30%
Lanx Publishes Favorable Study for ASPEN Minimally Invasive Spinal Fusion Device
Integra LifeSciences Receives FDA 510(k) Clearance for Titan Reverse Shoulder System